Form D · Private Equity Fund

Avego Healthcare Capital Fund II, L.P.

Alpharetta, GA · CIK 0001949892

Offering snapshot reported Oct 12, 2023 · SEC filing

Reported sold: $278M
Investors reported: 33
Minimum accepted: $0
First sale: Oct 14, 2022

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 33

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 12, 2023	Amendment	$278,050,000	No comparison	33	SEC filing
Oct 12, 2022	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $2M (estimated)
Finders' fees: $0
Form D file number: 021-461562

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
UBS Securities LLC	7654

Source: Form D, filed Oct 12, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

AVEGO HEALTHCARE CAPITAL FUND II, L.P.

Investment adviser: AVEGO MANAGEMENT, LLC

Gross asset value: $366M
Beneficial owners: 49
ADV minimum commitment: $0

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator NAV CONSULTING INC. OAKBROOK TERRACE, Illinois, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor COHNREZNICK LLP PARSIPPANY, New Jersey, United States

Custodian JPMORGAN CHASE BANK, NATIONAL ASSOCIATION NEW YORK, New York, United States Related to adviser: No

Marketer UBS SECURITIES LLC NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

COHNREZNICK LLP
PCAOB 596

JPMORGAN CHASE BANK, NATIONAL ASSOCIATION
LEI 7H6GLXDRUGQFU57RNE97

UBS SECURITIES LLC
CRD 7654 · SEC 8-22651

Filing source

Form ADV 2089033 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-7389651940

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A Avego Healthcare Capital Gp Ii, Llc	Director
James Flexner	Executive
Kevin Mc Neill	Executive
Alyssa Romano	Executive
Thomas Vandervort	Executive
Balaji Venkataraman	Executive
James Zenker	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

1055 B Powers Place, 2 Nd Floor
Alpharetta, GA, 30009